Skip to main content
. 2018 Sep 26;24(3):349–357. doi: 10.1634/theoncologist.2018-0150

Table 3. Cost‐effectiveness in the base‐case analyses.

image

a

First‐generation tyrosine kinase inhibitors compared with SOC (the reference strategy) for advanced non‐small cell lung cancer harboring epidermal growth factor receptor mutation.

Abbreviations: CNS, central nervous system; LY, life year; QALY, quality‐adjusted life year; SOC, standard of care.